Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Rivaroxaban price, strengths & recalls

Generic of Xarelto

Pharmacies pay $18.80 for 30 tablets of Rivaroxaban 2.5 mg tablet this week, and from $18.80 to $18.80 across its 2 priced strengths and forms. 17 manufacturers make it. It is in shortage (being discontinued). It has 3 recalls on record, none ongoing. Its official label last changed on October 1, 2026.

Being discontinuedGeneric
Pharmacies pay$18.80for 30 tablets of 2.5 mg tablet-3.6% in 4 weeks
Fair cash price
$32.12
Strengths
2
Makers
17
Updated
Nov 11

Rivaroxaban price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
1 mg/mL oral suspension$1.81$1.81 / 1 mL+1.4%
2.5 mg tablet$0.6265$18.80 / 30 tablets-3.6%-73.9%

Brand names of rivaroxaban

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Medicare negotiated price

$517.00$197.00-62%

Medicare negotiated a maximum fair price of $197.00 for a 30-day supply of Xarelto, against a 2023 list price of $517.00. It has applied since January 1, 2026.

What this means for patients

  • The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
  • What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
  • Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
  • If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Every Medicare negotiated price

Supply status: shortages & recalls

In shortage1 product is short or being discontinued
No ongoing recalls3 recalls on record, latest Apr 29, 2015

Shortages

  • Xarelto, For Suspension, 155 mg (NDC 50458-575-01)Janssen Pharmaceuticals · Being discontinued Sep 18, 2026 · Updated Sep 18, 2026Business Decision

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for rivaroxaban? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedOctober 1, 2026
Version4
EffectiveJul 17, 2026
Read the label

These highlights do not include all the information needed to use RIVAROXABAN TABLETS safely and effectively. See full prescribing information for RIVAROXABAN TABLETS.RIVAROXABAN tablets, for oral useInitial U.S. Approval: 2011

This drug has a boxed warning

WARNING: (A) PREMATURE DISCONTINUATION OF RIVAROXABAN INCREASES THE RISK OF THROMBOTIC EVENTS, (B) SPINAL/EPIDURAL HEMATOMA

A. Premature discontinuation of rivaroxaban increases the risk of thrombotic events

Premature discontinuation of any oral anticoagulant, including rivaroxaban, increases the risk of thrombotic events. If anticoagulation with rivaroxaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant [see Dosage and Administration (2.3, 2.4) and Warnings and Precautions (5.1)].

B. Spinal/epidural hematoma

Epidural or spinal hematomas have occurred in patients treated with rivaroxaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:

use of indwelling epidural catheters

concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants

a history of traumatic or repeated epidural or spinal punctures

a history of spinal deformity or spinal surgery

optimal timing between the administration of rivaroxaban and neuraxial procedures is not known [see Warnings and Precautions (5.2, 5.3) and Adverse Reactions (6.2)].

Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary [see Warnings and Precautions (5.3)].

Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis [see Warnings and Precautions (5.3)].

WARNING: (A) PREMATURE DISCONTINUATION OF RIVAROXABAN INCREASES THE RISK OF THROMBOTIC EVENTS, (B) SPINAL/EPIDURAL HEMATOMA

See full prescribing information for complete boxed warning.

(A) Premature discontinuation of rivaroxaban increases the risk of thrombotic events

Premature discontinuation of any oral anticoagulant, including rivaroxaban, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if rivaroxaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy. (2.2, 2.3, 5.1)

(B) Spinal/epidural hematoma

Epidural or spinal hematomas have occurred in patients treated with rivaroxaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. (5.2, 5.3, 6.2)

Monitor patients frequently for signs and symptoms of neurological impairment and if observed, treat urgently. Consider the benefits and risks before neuraxial intervention in patients who are or who need to be anticoagulated. (5.3)

Recent major changes (as listed on the label)

RECENT MAJOR CHANGES

Warnings and Precautions (5.2) 03/2026

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA022406 · Janssen Pharms
First approved
July 1, 2011 (15 years ago)
Latest approved change
March 24, 2026
Approved label
PDF, Mar 26, 2026
Generic makers
15 approved generic applications on the market
Last patent listed
August 17, 2034

Rivaroxaban questions

How much does rivaroxaban cost without insurance?

Pharmacies pay about $18.80 for 30 tablets of rivaroxaban 2.5 mg tablet ($0.6265 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $32.12. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of rivaroxaban?

Rivaroxaban is sold as Xarelto. The generic has the same active ingredient and usually costs far less.

Is rivaroxaban in shortage?

Yes. 1 product is listed as in shortage or being discontinued (being discontinued). See which ones.

Has rivaroxaban been recalled?

3 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the rivaroxaban label last change?

The official label was last updated on October 1, 2026 (version 4). See what changed.

Does Medicare have a negotiated price for Rivaroxaban?

Yes: $197.00 for a 30-day supply of Xarelto, from January 1, 2026. What you pay still depends on your plan.

Talk about rivaroxaban

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.